ArticleVeterinary medicine and science2025
The Effect of Florfenicol Given by Nebulization in the Treatment of Naturally Infected Calves With Bovine Respiratory Disease Complex: Randomized Clinical Study.
Article in Veterinary medicine and science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Epidemiological surveillance of BVDV, Pasteurella multocida, and Brucella spp. infections in cattle from Guizhou, China using a newly established triplex TaqMan qPCR assay.Veterinary research communications · 2026Article
- Epidemiological Investigation and Phylogenetic Analysis of Bovine Respiratory Disease Complex in Northern China.Veterinary medicine and science · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundBovine respiratory disease (BRD) is still one of the major problems for herd management due to the negative effects on herd health, costs due to treatment, reduced weight gain and calf loss. The aim of this study is to evaluate the effectiveness of aerosolized florfenicol in calves with naturally infected BRD.
methodsForty-five calves were included in the study and divided into three groups. Group 1 received florfenicol subcutaneous route. While Group 2 received florfenicol administered solely through nebulization, Group 3 received florfenicol via nebulization in addition to flunixin meglumine administered intramuscularly (IM). BRD pathogens were determined from bronchoalveolar lavage (BAL) samples. The treatment period was monitored with a clinical respiratory score, haematology, thorax ultrasonography and serum haptoglobin levels.
resultsMycoplasma bovis was the main primary bacterial pathogen isolated from BAL fluid, Escherichia coli was the main secondary bacterial pathogen and bovine respiratory syncytial virus (BRSV) was found to be the primary viral BRD pathogen. The treatment period was shortened to the 2nd day in the groups with nebulization. Calves with clinical respiratory scores of 12 and above died in all groups. There was no significant difference in lung ultrasonographic scoring and haematology results before and after treatment within the groups. There was a significant decrease in the high haptoglobin values before and after the 3rd day of treatment. The study's main limitation was that there was no negative control group in this study due to ethical reasons.
conclusionIt was concluded that florfenicol administered by inhalation in BRD patients is more effective, reduces the recovery time and will be a promising treatment strategy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.